Accuri Cytometers Sale Named Venture Exit Of The Year

The Michigan Venture Capital Association (MVCA) has awarded “Venture Exit of the Year” honors to the 2011 sale of Accuri Cytometers to Becton, Dickinson and Company (NYSE: BDX), a leading global medical technology company. Investors in Accuri that were honored at the MVCA event included Baird Venture Partners (BVP), Arboretum Ventures, Credit Suisse CFIG, Flagship, and Plymouth Venture Partners.

Based in Ann Arbor, Mich., Accuri is a worldwide provider of easy-to-use, cost-effective flow cytometers to the life sciences research community.

“We are very proud to have played a role in supporting Accuri from initial investment to exit,” said BVP Partner Pete Shagory. “We are very pleased that our peers in the venture capital community have recognized our efforts to build a successful company while also delivering value to investors.”

For more information on the award please visit MichiganVCA.org.